Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Assets Average (2016 - 2025)

Historic Assets Average for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $79.0 million.

  • Harvard Bioscience's Assets Average fell 3923.34% to $79.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.0 million, marking a year-over-year decrease of 3923.34%. This contributed to the annual value of $132.0 million for FY2024, which is 661.98% down from last year.
  • Harvard Bioscience's Assets Average amounted to $79.0 million in Q3 2025, which was down 3923.34% from $79.9 million recorded in Q2 2025.
  • Harvard Bioscience's Assets Average's 5-year high stood at $160.2 million during Q1 2022, with a 5-year trough of $79.0 million in Q3 2025.
  • In the last 5 years, Harvard Bioscience's Assets Average had a median value of $144.2 million in 2023 and averaged $136.3 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 419.02% in 2022, then crashed by 3923.34% in 2025.
  • Harvard Bioscience's Assets Average (Quarter) stood at $158.1 million in 2021, then dropped by 7.54% to $146.2 million in 2022, then fell by 5.22% to $138.6 million in 2023, then dropped by 6.94% to $128.9 million in 2024, then plummeted by 38.7% to $79.0 million in 2025.
  • Its Assets Average stands at $79.0 million for Q3 2025, versus $79.9 million for Q2 2025 and $103.2 million for Q1 2025.